[
  {
    "date": "2023-12-31",
    "symbol": "ALVOW",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "currentfiscalyearenddate": "--12-31",
    "documentperiodenddate": "2023-12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-41421",
    "entityregistrantname": "ALVOTECH",
    "entityincorporationstatecountrycode": "N4",
    "entityaddressaddressline1": 9,
    "entityaddressaddressline2": "Rue de Bitbourg",
    "entityaddresspostalzipcode": 1273,
    "entityaddresscityortown": "Luxembourg",
    "entityaddresscountry": "LU",
    "contactpersonnelname": "Robert Wessman",
    "cityareacode": 354,
    "localphonenumber": "422 4500",
    "security12btitle": "Ordinary Shares",
    "tradingsymbol": "ALVO",
    "securityexchangename": "NASDAQ",
    "entitycommonstocksharesoutstanding": 266821844,
    "classofwarrantsorrightsoutstanding": 10363094,
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1898416,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2023,
    "auditorname": "Deloitte ehf.",
    "auditorfirmid": 1490,
    "auditorlocation": "Kópavogur, Iceland",
    "revenuefromsaleofgoods": 48699000,
    "licencefeeincome": 42735000,
    "otherrevenue": 1948000,
    "costofsales": 160856000,
    "researchanddevelopmentexpense": 210827000,
    "generalandadministrativeexpense": 76559000,
    "profitlossfromoperatingactivities": -354860000,
    "shareofprofitlossofjointventuresaccountedforusingequitymethod": -7153000,
    "impairmentlossrecognisedinprofitorloss": 21519000,
    "financeincome": 4823000,
    "financecosts": 267157000,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": -5183000,
    "othergainslosses": -296189000,
    "profitlossbeforetax": -651049000,
    "incometaxexpensecontinuingoperations": -99318000,
    "profitloss": -551731000,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -86000,
    "comprehensiveincome": -551817000,
    "basicearningslosspershare": -2.43,
    "dilutedearningslosspershare": -2.43,
    "propertyplantandequipment": 236779000,
    "rightofuseassets": 119802000,
    "goodwill": 12058000,
    "intangibleassetsotherthangoodwill": 19076000,
    "noncurrentcontractassets": 10856000,
    "investmentsinjointventuresaccountedforusingequitymethod": 18494000,
    "othernoncurrentassets": 2244000,
    "noncurrentrestrictedcashandcashequivalents": 26132000,
    "deferredtaxassets": 309807000,
    "noncurrentassets": 755248000,
    "inventories": 74433000,
    "currenttradereceivables": 41292000,
    "currentcontractassets": 35193000,
    "othercurrentassets": 31871000,
    "tradeandothercurrentreceivablesduefromrelatedparties": 896000,
    "cashandcashequivalents": 11157000,
    "currentassets": 194842000,
    "assets": 950090000,
    "issuedcapital": 2279000,
    "sharepremium": 1229690000,
    "otherreserves": 42911000,
    "reserveofexchangedifferencesontranslation": -1528000,
    "retainedearnings": -2205845000,
    "equity": -932493000,
    "longtermborrowings": 922134000,
    "noncurrentderivativefinancialliabilities": 520553000,
    "noncurrentleaseliabilities": 105632000,
    "noncurrentcontractliabilities": 73261000,
    "deferredtaxliabilities": 53000,
    "noncurrentliabilities": 1621633000,
    "tradeandothercurrentpayables": 80563000,
    "currentleaseliabilities": 9683000,
    "currentportionoflongtermborrowings": 38025000,
    "tradeandothercurrentpayablestorelatedparties": 9851000,
    "currentcontractliabilities": 59183000,
    "currenttaxliabilitiescurrent": 925000,
    "othercurrentliabilities": 62720000,
    "currentliabilities": 260950000,
    "liabilities": 1882583000,
    "equityandliabilities": 950090000,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": 78000,
    "adjustmentsfordepreciationandamortisationexpense": 24210000,
    "adjustmentsforimpairmentlossreversalofimpairmentlossrecogniseinprofitorlossintangibleassets": 1779000,
    "increasedecreaseinallowanceaccountforcreditlossesoffinancialassets": -18500000,
    "changesininventoryreserves": 8341000,
    "lossesondisposalsofpropertyplantandequipment": 365000,
    "adjustmentsforundistributedprofitsofinvestmentsaccountedforusingequitymethod": -7153000,
    "adjustmentsforfinanceincome": 4823000,
    "adjustmentsforfinancecosts": 267157000,
    "adjustmentsforsharebasedpayments": 18033000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 5183000,
    "adjustmentsforincometaxexpense": -99318000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -283554000,
    "adjustmentsfordecreaseincreaseininventories": -11304000,
    "adjustmentsfordecreaseincreaseintradeaccountreceivable": -8320000,
    "adjustmentsforincreasedecreaseinliabilitiestorelatedparties": 2161000,
    "adjustmentsfordecreaseincreaseincontractassets": -17393000,
    "adjustmentsfordecreaseincreaseinotherassets": -802000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 31772000,
    "adjustmentsforincreasedecreaseincontractliabilities": 35396000,
    "adjustmentsforincreasedecreaseinotherliabilities": -5182000,
    "cashflowsfromusedinoperations": -257226000,
    "interestreceivedclassifiedasoperatingactivities": 3649000,
    "interestpaidclassifiedasoperatingactivities": 57254000,
    "incometaxespaidclassifiedasoperatingactivities": 1354000,
    "cashflowsfromusedinoperatingactivities": -312185000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 33234000,
    "proceedsfromsalesofpropertyplantandequipmentclassifiedasinvestingactivities": 133000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 13239000,
    "cashflowsfromusedininvestingactivities": -46340000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 99367000,
    "repaymentsofprincipalportionofleaseliabilities": 8269000,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 278831000,
    "proceedsfromissuingotherequityinstruments": 136879000,
    "paymentsforshareissuecosts": 4141000,
    "proceedsfromexerciseofwarrants": 6390000,
    "paymentsfordebtissuecosts": 9004000,
    "cashflowsfromusedinfinancingactivities": 301319000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -57206000,
    "effectofexchangeratechangesoncashandcashequivalents": 1936000,
    "issueofequity": 6000,
    "increasedecreasethroughsharebasedpaymenttransactions": 16985000,
    "increasedecreasethroughtransactionswithowners": 118000,
    "increasedecreasethroughexerciseofwarrantsequity": 25000,
    "increasedecreasethroughconversionofconvertibleinstruments": 5356000,
    "disclosureofrevenueandotheroperatingincomeexplanatorytextblock": "Revenue",
    "disclosureofsalariesandotheremployeeexpensesexplanatorytextblock": "Salaries and other employee expenses",
    "disclosureofdepreciationamortizationandimpairmentexplanatorytextblock": "Depreciation, amortization and impairment",
    "disclosureofauditfeesexplanatorytextblock": "Audit fees",
    "disclosureoflongtermincentiveplansexplanatorytextblock": "Long-term incentive plans",
    "disclosureoflitigationsettlementsexplanatorytextblock": "Litigation",
    "disclosureinentiretyofsupplementalcashflowinformationexplanatorytextblock": "Supplemental cash flow information",
    "descriptionofaccountingpolicyforcriticalaccountingjudgmentsandkeysourcesofestimationuncertaintyexplanatorypolicytextblock": "Critical accounting judgments and key sources of estimation uncertainty",
    "descriptionofaccountingpolicyforcostofproductrevenueexplanatorypolicytextblock": "Cost of product revenue Cost of product revenue includes the cost of inventory sold, labor costs, manufacturing overhead expenses and reserves for expected scrap, as well as shipping and freight costs and royalty costs related to in-license agreements.",
    "descriptionofaccountingpolicyforlitigationandothercontingenciesexplanatorypolicytextblock": "Litigation and other contingencies",
    "scheduleoffairvalueofsharesissuedandnoncashsharelistingexpensetabletextblock": "The fair value of shares issued was estimated based on a market price of $9.38 per share as of 15 June 2022.",
    "disclosureofestimatedusefullivesotherintangibleassetsexplanatorytabletextblock": "The following useful lives are used in the calculation of amortization:",
    "disclosureofestimatedusefullivesofpropertyplantandequipmentexplanatorytabletextblock": "The following useful lives are used in the calculation of depreciation:",
    "disclosureofdetailedinformationaboutnoncurrentassetsexcludingfinancialinstrumentsanddeferredtaxassetsexplanatorytabletextblock": "Non-current assets, excluding financial instruments and deferred tax assets, based on the location of the asset is as follows: 20232022Europe415,659 334,837 North America5,094 240 Asia and Other6,194 3,715 426,947 338,792",
    "disclosureofdetailedinformationaboutaggregatesalaryandotheremployeeexpensestabletextblock": "The aggregate salary and other employee expenses incurred by the Group for these employees were as follows:",
    "disclosureofdetailedinformationaboutsalariesandotheremployeeexpensesincludedinconsolidatedstatementsofprofitorlossexplanatorytabletextblock": "Salaries and other employee expenses are included within the consolidated statements of profit or loss and other comprehensive income or loss as follows: 202320222021Cost of product revenue76,908 42,501 — Research and development expenses44,339 52,962 71,588 General and administrative expenses43,662 39,977 37,932 Total salary and other employee expenses164,909 135,440 109,520",
    "disclosureofdetailedinformationaboutdepreciationamortizationandimpairmentexplanatorytabletextblock": "Depreciation, amortization and impairment expenses incurred during the years ended 31 December 2023, 2022, and 2021 are as follows: 202320222021Depreciation and impairment of property, plant and equipment (see Note 12)14,353 9,807 10,666 Depreciation of right of use assets (see Note 13)8,913 9,869 8,699 Amortization and impairment of intangible assets (see Note 15)2,723 3,488 4,916 25,989 23,164 24,281",
    "disclosureofdetailedinformationaboutdepreciationamortizationandimpairmentexpenseincludedinconsolidatedstatementsprofitorlossandothercomprehensiveincomeorlossexplanatorytabletextblock": "Depreciation, amortization and impairment expenses are included within the consolidated statements of profit or loss and other comprehensive income or loss as follows: 202320222021Cost of product revenue15,582 10,053 — Research and development expenses6,886 9,757 21,764 General and administrative expenses3,521 3,354 2,517 Total depreciation, amortization and impairment expense25,989 23,164 24,281",
    "disclosureofdetailedinformationaboutauditfeesexplanatorytabletextblock": "202320222021Financial Statement audit fees2,876 2,615 5,502 Other fees, including tax services462 676 136 Total fees3,339 3,291 5,638",
    "disclosureofdetailedinformationaboutmajorcomponentsofincometaxexplanatorytabletextblock": "Taxation recognized in the consolidated statements of profit or loss and other comprehensive income or loss during the years ended 31 December 2023, 2022, and 2021 is as follows: Current tax202320222021Direct taxes - current1,307 1,015 706 Direct taxes – prior year(60)(115)491 Total current tax1,247 900 1,197 Deferred tax   Current(89,847)(54,236)(48,414)Prior year(10,718)15,269 (477)Total deferred tax(100,565)(38,967)(48,891)Total income tax benefit(99,318)(38,067)(47,694)",
    "disclosureofdetailedinformationabouteffectivetaxratereconciliationexplanatorytabletextblock": "The reconciling items between the statutory rate and the effective tax rate are as follows:",
    "disclosureofdetailedinformationaboutreconciliationofchangesindeferredtaxliabilityassetexplanatorytabletextblock": "The movement in net deferred taxes during the years ended 31 December 2023 and 2022 is as follows: 20232022Balance at 1 January209,187 170,268 Deferred tax credited to profit or loss100,567 38,919 Balance at 31 December309,754 209,187 Deferred tax assets309,807 209,496 Deferred tax liabilities(53)(309)",
    "disclosureofdetailedinformationaboutdeferredtaxrecognizedintheconsolidatedstatementsoffinancialpositionexplanatorytabletextblock": "The amount of deferred tax recognized in the consolidated statements of financial position as of 31 December 2023 and 2022 is as follows: 20232022Deferred tax assets attributable to temporary differences in respect of tax losses301,375 205,290 Deferred tax assets attributable to other temporary differences11,941 6,832 Deferred tax liabilities attributable to other temporary differences(3,562)(2,935)Net deferred tax assets309,754 209,187",
    "disclosureofdetailedinformationaboutexpirationofunusedtaxlossesexplanatorytabletextblock": "These tax losses expire as follows: 2024-202668,821 2027-2029289,608 Later1,155,294 1,513,723",
    "disclosureofdetailedinformationaboutclassesofrightofuseassetsexplanatorytabletextblock": "The Group’s right-of-use assets as of 31 December 2023 and 2022 are comprised of the following: 20232022Right-of-use assetsFacilities110,692 41,702 Fleet389 339 Equipment8,721 5,460 119,802 47,501",
    "disclosureofdetailedinformationaboutleaseliabilitiesexplanatorytabletextblock": "The Group’s lease liabilities and the movements during the years ended 31 December 2023 and 2022 are as follows:",
    "disclosureofdetailedinformationaboutmaturityanalysisforleaseliabilitiesexplanatorytabletextblock": "The maturity analysis of undiscounted lease payments as of 31 December 2023 and 2022 is as follows: 20232022Less than one year14,637 6,000 One to five years51,053 20,160 Thereafter89,682 22,274 155,372 48,434",
    "disclosureofdetailedinformationaboutcashandcashequivalentsexplanatorytabletextblock": "Cash and cash equivalents as of 31 December 2023 and 2022 are as follows:",
    "disclosureofdetailedinformationaboutrestrictedcashandcashequivalentsexplanatorytabletextblock": "Movements in restricted cash balances during the years ended 31 December 2023 and 2022 are as follows:",
    "disclosureofdetailedinformationaboutinventoriesexplanatorytabletextblock": "The Group’s inventory balances as of 31 December 2023 and 2022 are as follows: 20232022Raw materials and supplies51,524 41,961 Work in progress33,068 29,450 Finished goods244 2,121 Inventory reserves(10,403)(2,062)Balance at 31 December74,433 71,470",
    "disclosureofdetailedinformationaboutothercurrentassetsexplanatorytabletextblock": "The composition of other current assets as of 31 December 2023 and 2022 is as follows:20232022Value-added tax8,801 6,468 Prepaid expenses22,035 20,601 Proceeds receivable from Convertible Bonds (see Note 21)— 3,520 Derivative asset— 851 Other short-term receivables1,035 1,509  31,871 32,949",
    "scheduleofotherreservestabletextblock": "The composition of other reserves as of 31 December 2023 and 2022 is as follows:20232022Equity component of convertible bonds21,391 16,034 Share based payments21,520 14,548 42,911 30,582",
    "scheduleofmaturitiesofoutstandingborrowingsexplanatorytabletextblock": "Contractual maturities of principal amounts on the Group’s outstanding borrowings as of 31 December 2023 and 2022 are as follows: 20232022Within one year38,025 19,916 Within two years867,273 3,804 Within three years4,932 696,646 Within four years37,857 3,374 Thereafter12,072 40,830  960,159 764,570",
    "disclosureofdetailedinformationaboutboardofdirectorsandkeymanagerialpersonnelexplanatorytabletextblock": "The Board of Directors’ remuneration is shown in the table below.",
    "disclosureofdetailedinformationaboutothercurrentliabilitiesexplanatorytabletextblock": "The composition of other current liabilities as of 31 December 2023 and 2022 is as follows:",
    "disclosureofdetailedinformationaboutjointventureexplanatorytabletextblock": "Name of entityPlace of businessOwnership interest Carrying Amount2023202220232022Alvotech & CCHN Biopharmaceutical Co., Ltd.China50 %50 %18,494 48,568",
    "disclosureofdetailedinformationaboutchangesininvestmentinjointventureexplanatorytabletextblock": "The following table provides the change in the Group’s investment in a joint venture during the years ended 31 December 2023 and 2022: 20232022Balance at 1 January48,568 55,307 Share in losses(7,153)(2,590)Impairment loss on investment in joint venture(21,519)— Translation difference(1,402)(4,149)Balance at 31 December18,494 48,568",
    "disclosureintabularformofcarryingamountandfinancialamountofcertainborrowingsexplanatorytabletextblock": "Material differences between the fair values and carrying amounts of these borrowings are identified as follows:",
    "disclosureintabularformofinterestratesensitivityanalysisimpactonprofitbeforetaxexplanatorytabletextblock": "The following table provides an interest rate sensitivity analysis for the effect on loss before tax: 20232022Variable-rate financial instruments +100(89)(186)Variable-rate financial instruments -10089 186",
    "disclosureintabularformofforeignexchangerateexplanatorytabletextblock": "Below are the foreign currencies that have the most significant impact on the Group’s operations. Closing rateAverage rateChange2023202220232022EUR1.105 1.061 1.091 1.052 4.1 %GBP1.275 1.204 1.266 1.233 5.9 %ISK0.007 0.007 0.007 0.007 5.1 %CHF1.188 1.071 1.156 1.047 10.9 %INR0.012 0.012 0.012 0.013 0.1 %",
    "disclosureintabularformofassetsandliabilitiesdenominatedinforeigncurrenciesexplanatorytabletextblock": "The Group’s assets and liabilities that are denominated in foreign currencies as of 31 December 2023 are as follows:  AssetsLiabilitiesNetassets EUR36,568 46,303 (9,735)GBP69 3,479 (3,410)ISK3,247 144,812 (141,565)CHF335 7,488 (7,153)INR167 536 (369)The Group’s assets and liabilities that are denominated in foreign currencies as of 31 December 2022 are as follows: AssetsLiabilitiesNet assets EUR36,420 26,514 9,906 GBP111 1,538 (1,427)ISK49,484 109,507 (60,023)CHF69 7,305 (7,236)INR11 517 (506)",
    "disclosureintabularformofcurrencyrisksensitivityanalysisonprofitbeforetaxexplanatorytabletextblock": "The analysis assumes that all other variables, such as interest rates, remain constant.",
    "numberofsharescalledbyeachwarrantorright": 1,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 3745781,
    "proportionofownershipinterestinsubsidiary": 1,
    "maximumpercentageofownershipinterestheldbyeachshareholder": 2.4,
    "currentassetsliabilities": -66100000,
    "proceedsfromissueofordinaryshares": 6300000,
    "increasedecreaseinnumberofordinarysharesissued": 2479962,
    "numberofsharesissuedandfullypaid": 3893650,
    "proportionofownershipinterestinjointventure": 0.5,
    "numberofoperatingsegments1": 1,
    "amountspayablerelatedpartytransactions": 76556000,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P3Y",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P40Y",
    "revenuefromcontractswithcustomers": 63510000,
    "noncurrentassetsotherthanfinancialinstrumentsdeferredtaxassetspostemploymentbenefitassetsandrightsarisingunderinsurancecontracts": 415659000,
    "revenue": 9430000,
    "percentageofentitysrevenue": 0.103,
    "contractassets": 46049000,
    "increasedecreasethroughcumulativecatchupadjustmentstorevenuecontractassets": 19634000,
    "contractassetsadditionsamountstransferredtotradereceivables": 2412000,
    "contractliabilities": 132444000,
    "contractliabilitiesadditionsderecognitionofcontractliability": 42089000,
    "contractliabilitycustomerprepayments": 100555000,
    "increasedecreasethroughcumulativecatchupadjustmentstorevenuearisingfromchangeinmeasureofprogresscontractliabilities": -23101000,
    "contractassetsliabilitiesforeigncurrencyadjustment": 171000,
    "noncurrentcontractassetsmaterializeperiod": "P2Y",
    "noncurrentcontractliabilitiesrevenuerecognitionperiod": "P2Y",
    "transactionpriceallocatedtoremainingperformanceobligations": 383000000,
    "transactionpriceallocatedtoremainingperformanceobligationsperiod": "P5Y",
    "averagenumberofemployees": 999000,
    "wagesandsalaries": 107067000,
    "postemploymentbenefitexpensedefinedcontributionplans": 11518000,
    "otherlongtermbenefits": 78000,
    "expensefromsharebasedpaymenttransactionswithemployees": 18033000,
    "otheremployeeexpense": 19718000,
    "temporarylabourexpense": 8495000,
    "employeebenefitsexpense": 164909000,
    "interestincomeoncashandcashequivalents": 4547000,
    "interestincomeonotherfinancialassets": 276000,
    "lossesonchangeinfairvalueofderivatives": 132333000,
    "interestexpenseonborrowings": 129327000,
    "interestexpenseonleaseliabilities": 3840000,
    "amortizationofdeferreddebtissuancecosts": 1657000,
    "depreciationandimpairmentofpropertyplantandequipment": 14353000,
    "depreciationrightofuseassets": 8913000,
    "amortizationandimpairmentofintangibleassets": 2723000,
    "depreciationamortisationandimpairmentlossreversalofimpairmentlossrecognisedinprofitorloss": 25989000,
    "auditorsremunerationforauditservices": 2876000,
    "auditorsremunerationfortaxservices": 462000,
    "auditorsremuneration": 3339000,
    "currenttaxexpenseincome": 1307000,
    "adjustmentsforcurrenttaxofpriorperiod": -60000,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": 1247000,
    "deferredtaxexpenseincome": -89847000,
    "adjustmentsfordeferredtaxofpriorperiods": -10718000,
    "deferredtaxexpenseincomeandadjustmentsfordeferredtaxofpriorperiods": -100565000,
    "averageeffectivetaxrate": 0.153,
    "netdeferredtaxliabilities": 53000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 68821000,
    "applicabletaxrate": 0.249,
    "taxrateeffectofforeigntaxrates": -0.034,
    "taxrateeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": -0.067,
    "taxrateeffectofnonrecognitionoftaxlosses": -0.015,
    "othertaxrateeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": 0.02,
    "deferredtaxliabilityasset": -309754000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": -100567000,
    "netdeferredtaxassets": 309807000,
    "numberofpotentialordinarysharesthatareantidilutiveinperiodpresented": 86745377,
    "weightedaverageshares": 227256469,
    "adjustedweightedaverageshares": 227256469,
    "increasedecreasethroughtransferspropertyplantandequipment": 2771000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 29351000,
    "disposalspropertyplantandequipment": 1233000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": 679000,
    "depreciationpropertyplantandequipment": 2875000,
    "propertyplantandequipmentpledgedassecurity": 127400000,
    "adjustmentsforindexedleasesrightofuseassets": 7354000,
    "additionstorightofuseassets": 74109000,
    "cancellationsrightofuseassets": 139000,
    "reclassificationrightofuseassets": 443000,
    "translationdifferencerightofuseassets": 333000,
    "weightedaverageremainingleaseterm": "P15Y",
    "areaofproperty": 140000,
    "expenserelatingtoshorttermleasesandleasesoflowvalueassetsforwhichrecognitionexemptionhasbeenused": 700000,
    "leaseliabilities": 115315000,
    "leaseliabilitiesadjustmentsforindexedleases": 7405000,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 72882000,
    "leaseliabilitiescancelledlease": 167000,
    "cashoutflowforleases": 7260000,
    "leaseliabilitiesforeigncurrencyadjustment": 1932000,
    "leaseliabilitiestranslationdifference": -9000,
    "foreigncurrencydifferenceonleaseliability": -1932000,
    "lossfromextinguishmentofleaseliabilities": 28000,
    "leasecostrecognizedinprofitandloss": 14713000,
    "grossleaseliabilities": 14637000,
    "increasedecreasethroughnetexchangedifferencesgoodwill": 415000,
    "descriptionofgrowthrateusedtoextrapolatecashflowprojections": 0.05,
    "descriptionofdiscountratesappliedtocashflowprojections": 0.25,
    "increasedecreasethroughtransfersintangibleassetsotherthangoodwill": 1002000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 4094000,
    "impairmentlossrecognisedinprofitorlossintangibleassetsotherthangoodwill": 1779000,
    "disposalsandretirementsintangibleassetsotherthangoodwill": 15000000,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsotherthangoodwill": 72000,
    "amortisationintangibleassetsotherthangoodwill": 626000,
    "impairmentloss": 1800000,
    "paymentforcontractualcommitment": 3000000,
    "contractualcapitalcommitments": 25000000,
    "contractualcapitalcommitmentcontingentliability": 15000000,
    "contractualcapitalcommitmentsterm": "P10Y",
    "interestincomeoncash": 945000,
    "rawmaterialsandconsumablesused": 51524000,
    "workinprogress": 33068000,
    "finishedgoods": 244000,
    "inventoryreserves": 10403000,
    "costofinventoriesrecognisedasexpenseduringperiod": 42800000,
    "inventorywritedown2011": 10400000,
    "currentvalueaddedtaxreceivables": 8801000,
    "currentprepaidexpenses": 22035000,
    "othercurrentreceivables": 1035000,
    "derecognitionprepaiddevelopmentcosts": 3500000,
    "numberofsharesoutstanding": 266821844,
    "commonstockheldbysubsidiaries": 22905618,
    "numberofsharesissued": 266821844,
    "sharecapitalandsharepremium": 1231969000,
    "capitalcontributionsharesissued": 11834061,
    "capitalcontributionvalue": 118000,
    "vestedearnoutsharesvalue": 6000,
    "reserveofequitycomponentofconvertibleinstruments": 21391000,
    "reserveofsharebasedpayments": 21520000,
    "bondsissued": 549411000,
    "loansreceived": 76556000,
    "otherborrowings": 97615000,
    "borrowings": 960159000,
    "issuesfairvaluemeasurementliabilities": 45555000,
    "borrowingsinterestrate": 0.1273,
    "classofwarrantsorrightsexercisepricepershare": 11.5,
    "numberoftranches": 2,
    "borrowingsredemptionconversionprice": 10,
    "financialliabilitiesatfairvalue": 118830000,
    "numberofloans": 2,
    "borrowingsadjustmenttointerestratebasis": 0.0475,
    "financialassetspledgedascollateralforliabilitiesorcontingentliabilities": 25000000,
    "paymentsfordebtissuecost": 6115000,
    "accretionderecognitionofborrowingsdiscount": 15770000,
    "recognitionofnewborrowingsdiscount": 50953000,
    "proceedsfromborrowingclassifiedasfinancingactivities": 275311000,
    "repaymentsofborrowingclassifiedasfinancingactivities": 99367000,
    "debtinstrumentincreaseaccruedinterests": 58212000,
    "amortizationofdeferreddebtissuecosts": 1657000,
    "increasedecreasethrougheffectofchangesinforeignexchangeratesliabilitiesarisingfromfinancingactivities": 1075000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": 145358000,
    "interestcostscapitalizedperiodincreasedecrease": 1657000,
    "gainslossesrecognisedinprofitorlossattributabletochangeinunrealisedgainsorlossesforliabilitiesheldatendofperiodfairvaluemeasurement": -36071000,
    "noncashchangesinotherchanges": 27603000,
    "proceedsfromcurrentborrowings": 3500000,
    "numberofemployees": 2,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 1755291,
    "numberofyearforissuingsharesaftertheclosingofthebusinesscombination": "P1Y",
    "paymentsfromplannetdefinedbenefitliabilityasset": 1500000,
    "liabilitiesfromsharebasedpaymenttransactionscashsettlementfairvalue": 800000,
    "decreaseinequityfromsharebasedpaymenttransactionscashsettlementfairvalue": 700000,
    "increasedecreaseinnetdefinedbenefitliabilityasset": -36800000,
    "changesinequity": 31000000,
    "increasedecreasethroughothercurrentliabilitiesandincomenetdefinedbenefitliabilityasset": 1500000,
    "liabilitiesfromsharebasedpaymenttransactions2011": 700000,
    "numberofshareoptionsaftertaxwitholdinginsharebasedpaymentarrangement": 2465845,
    "liabilityassetofdefinedbenefitplans": 659000,
    "contributionstoplannetdefinedbenefitliabilityasset": 78000,
    "numberofinstrumentsotherequityinstrumentsgranted": 820602,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 1587929,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 2466374,
    "weightedaveragefairvaluepershareotherequityinstrumentsoutstanding": 7.04,
    "weightedaveragefairvaluepershareotherequityinstrumentsgranted": 8.79,
    "weightedaveragefairvaluepershareotherequityinstrumentsforfeited": 7.11,
    "weightedaveragefairvaluepershareotherequityinstrumentsvested": 6.67,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 18000000,
    "numberoflitigations": 4,
    "numberofleaseagreementsenteredinto": 17,
    "numberofleaseagreements": 15,
    "servicesreceivedrelatedpartytransactions": 11968000,
    "revenuefromrenderingofservicesrelatedpartytransactions": 4000,
    "amountsreceivablerelatedpartytransactions": 16000,
    "directorfees": 156000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 26000,
    "keymanagementpersonnelcompensationotherlongtermbenefits": 104000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 1491000,
    "keymanagementpersonnelcompensationterminationbenefits": 52000,
    "currentaccruedsalaryandsalaryrelatedexpenses": 31340000,
    "currentaccruedinterest": 3333000,
    "currentaccruedvacation": 6075000,
    "currentemployeeincentiveplan": 659000,
    "currentaccruedexpensesandothercurrentliabilities": 21313000,
    "principalplaceofbusinessofjointventure": "China",
    "shareofgainslossesofjointventuresonexchangedifferencesontranslationnetoftax": -1402000,
    "othercurrentasset": 1035000,
    "othernoncurrentasset": 336000,
    "financialassetsatamortisedcost": 80848000,
    "othercurrentliability": 61873000,
    "financialliabilitiesatamortizedcostandfinancialliabilitiesatfairvaluethroughprofitorloss": 1748314000,
    "bondsissuedatfairvalue": 559867000,
    "derivativefinancialliabilities": 19715000,
    "gainslossesrecognisedinprofitorlossfairvaluemeasurementliabilities": 35220000,
    "transfersoutoflevel3offairvaluehierarchyliabilities": 45325000,
    "settlementsfairvaluemeasurementliabilities": 851000,
    "conversionprice": 0.01,
    "trancheofseniorbondwarrantspercentage": 0.015,
    "aggregateperiodfordeterminingtheshareprice": "P5Y",
    "sharesprice": 15,
    "thresholddaysfordeterminingtheshareprice": "P10D",
    "numberofconsecutivetradingdays": "P20D",
    "vestingpercentageofshares": 0.5,
    "significantunobservableinputliabilities": 11.48,
    "percentageofreasonablypossibleincreaseinunobservableinputliabilities": 0.1,
    "percentageofreasonablypossibledecreaseinunobservableinputliabilities": 0.1,
    "increasedecreaseinfairvaluemeasurementduetoreasonablypossibleincreaseinunobservableinputrecognisedinprofitorlossbeforetaxliabilities": -89000,
    "increasedecreaseinfairvaluemeasurementduetoreasonablypossibledecreaseinunobservableinputrecognisedinprofitorlossbeforetaxliabilities": 89000,
    "closingforeignexchangerate": 1.105,
    "averageforeignexchangerate": 1.091,
    "percentagechangeinforeignexchangerate": 0.041,
    "netassetsliabilities": -9735000,
    "maximumexposuretocreditrisk": 11157000,
    "financialassets": 43223000,
    "financialliabilities": 142436000,
    "capitalexpendituretangibleassetsincurredbutnotpaid": 2266000,
    "capitalexpenditureintangibleassetsincurredbutnotpaid": 930000,
    "rightofuseassetsobtainedthroughnewoperatingleaseliabilities": 74109000,
    "increasedecreasethroughsettlementofliabilitywithshares": 678000
  },
  {
    "date": "2022-12-31",
    "symbol": "ALVOW",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "currentfiscalyearenddate": "December 31",
    "entityregistrantname": "ALVOTECH",
    "entitycentralindexkey": 1898416,
    "entityfilenumber": "001-41421",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityshellcompany": "true",
    "entityfilercategory": "Non-accelerated filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityincorporationstatecountrycode": "Grand Duchy of Luxembourg",
    "contactpersonnelname": "Robert Wessman",
    "entityaddressaddressline1": "Sæmundargata 15-19",
    "entityaddressaddressline2": "Rue de Bitbourg",
    "entityaddresscityortown": "Reykjavík",
    "entityaddresspostalzipcode": 102,
    "entityaddresscountry": "Iceland",
    "cityareacode": 354,
    "localphonenumber": "422 4500",
    "entitycommonstocksharesoutstanding": 248649506,
    "documentaccountingstandard": "International Financial Reporting Standards",
    "icfrauditorattestationflag": "false",
    "security12btitle": "Warrants",
    "tradingsymbol": "ALVOW",
    "securityexchangename": "Nasdaq Stock Market LLC",
    "auditorname": "Deloitte ehf.",
    "auditorfirmid": 1490,
    "auditorlocation": "Kópavogur, Iceland",
    "revenuefromsaleofgoods": 24836000,
    "licencefeeincome": 58193000,
    "otherrevenue": 1988000,
    "costofsales": 64095000,
    "researchanddevelopmentexpense": 180622000,
    "generalandadministrativeexpense": 22900000,
    "profitlossfromoperatingactivities": -346442000,
    "shareofprofitlossofjointventuresaccountedforusingequitymethod": -2590000,
    "financeincome": 2549000,
    "financecosts": 188419000,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": 10566000,
    "gainlossarisingfromdifferencebetweencarryingamountoffinancialliabilityextinguishedandconsiderationpaid": -27311000,
    "othergainslosses": -205205000,
    "profitlossbeforetax": -551647000,
    "incometaxexpensecontinuingoperations": -38067000,
    "profitloss": -5180000,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -6111000,
    "comprehensiveincome": -513580000,
    "basicearningslosspershare": -2.6,
    "dilutedearningslosspershare": -2.6,
    "propertyplantandequipment": 440000,
    "rightofuseassets": 5460000,
    "goodwill": 11643000,
    "intangibleassetsotherthangoodwill": 15000000,
    "noncurrentcontractassets": 3286000,
    "investmentsinjointventuresaccountedforusingequitymethod": 48568000,
    "othernoncurrentassets": 5780000,
    "noncurrentrestrictedcashandcashequivalents": 25187000,
    "deferredtaxassets": 209500000,
    "noncurrentassets": 107487000,
    "inventories": 250000,
    "currenttradereceivables": 32972000,
    "currentcontractassets": 25370000,
    "othercurrentassets": 1539000,
    "tradeandothercurrentreceivablesduefromrelatedparties": 1548000,
    "cashandcashequivalents": 56050000,
    "currentassets": 18992000,
    "assets": 11000,
    "issuedcapital": 2126000,
    "sharepremium": 1058432000,
    "otherreserves": 30582000,
    "reserveofexchangedifferencesontranslation": -1442000,
    "retainedearnings": -1654114000,
    "equity": 1060558000,
    "longtermborrowings": 744654000,
    "noncurrentderivativefinancialliabilities": 380232000,
    "noncurrentpayablestorelatedparties": 7440000,
    "noncurrentleaseliabilities": 35369000,
    "noncurrentrecognisedliabilitiesdefinedbenefitplan": 544000,
    "noncurrentcontractliabilities": 57017000,
    "deferredtaxliabilities": 309000,
    "noncurrentliabilities": 15069000,
    "tradeandothercurrentpayables": 49188000,
    "currentleaseliabilities": 5163000,
    "currentportionoflongtermborrowings": 19916000,
    "tradeandothercurrentpayablestorelatedparties": 1131000,
    "currentcontractliabilities": 36915000,
    "currenttaxliabilitiescurrent": 934000,
    "othercurrentliabilities": 14129000,
    "currentliabilities": 14274000,
    "liabilities": 517000,
    "equityandliabilities": 828443000,
    "adjustmentsforextinguishmentofliabilitylossesgains": -4803000,
    "adjustmentsforsharelistingexpense": 83411000,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": 5492000,
    "adjustmentsfordepreciationandamortisationexpense": 20409000,
    "adjustmentsforimpairmentlossreversalofimpairmentlossrecogniseinprofitorlossintangibleassets": 2755000,
    "adjustmentsforundistributedprofitsofinvestmentsaccountedforusingequitymethod": -2590000,
    "financeincomereceivedclassifiedasoperatingactivities": -2549000,
    "financecostspaidclassifiedasoperatingactivities": -188419000,
    "adjustmentsforsharebasedpayments": 10317000,
    "adjustmentsforunrealisedforeignexchangelossesgains": -10566000,
    "adjustmentsforincometaxexpense": -38067000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -228861000,
    "adjustmentsfordecreaseincreaseininventories": -32412000,
    "adjustmentsfordecreaseincreaseintradeaccountreceivable": -3576000,
    "adjustmentsforincreasedecreaseinliabilitiestorelatedparties": 56000,
    "adjustmentsfordecreaseincreaseincontractassets": -9218000,
    "adjustmentsfordecreaseincreaseinotherassets": -17194000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 16442000,
    "adjustmentsforincreasedecreaseincontractliabilities": 19396000,
    "adjustmentsforincreasedecreaseinotherliabilities": -21384000,
    "cashflowsfromusedinoperations": -276751000,
    "interestreceivedclassifiedasoperatingactivities": 568000,
    "interestpaidclassifiedasoperatingactivities": 35372000,
    "incometaxespaidclassifiedasoperatingactivities": 834000,
    "cashflowsfromusedinoperatingactivities": -312389000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 37880000,
    "proceedsfromsalesofpropertyplantandequipmentclassifiedasinvestingactivities": 379000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 11122000,
    "restrictedcashinconnectionwithamendedbondagreement": 14914000,
    "cashflowsfromusedininvestingactivities": -63537000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 50000000,
    "repaymentsofprincipalportionofleaseliabilities": 11147000,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 193678000,
    "proceedsfromissuingshares": 9800000,
    "paymentsfordebtissuecosts": 12102000,
    "grossproceedsfromthepipefinancing": -174930000,
    "grosspipefinancingfeespaid": 5562000,
    "proceedsfromthecapitalreorganization": -9827000,
    "cashadvancesandloansfromrelatedparties": 160000000,
    "cashrepaymentsofadvancesandloansfromrelatedparties": 50000000,
    "cashflowsfromusedinfinancingactivities": 424910000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 48984000,
    "effectofexchangeratechangesoncashandcashequivalents": -113000,
    "increasedecreasethroughpipefinancing": 169368000,
    "increasedecreasethroughsettlementofliabilitywithshares": 30302000,
    "increasedecreasethroughcapitalreorganization": -171565000,
    "increasedecreasethroughsettlementofrelatedpartyloanswithordinaryshares": 32200000,
    "increasedecreasethroughsharebasedpaymenttransactions": 14548000,
    "increasedecreasethroughconversionofconvertibleinstruments": 16034000,
    "numberofinstrumentsgrantedinsharebasedpaymentarrangement": 1250000,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 6979486,
    "acquisitionrelatedcostsfortransactionrecognisedseparatelyfromacquisitionofassetsandassumptionofliabilitiesinbusinesscombination": 28500000,
    "expensecapitalized": 5600000,
    "proportionofownershipinterestinsubsidiary": 0.23500000000000001,
    "maximumpercentageofownershipinterestheldbyeachshareholder": 2.4,
    "currentassetsliabilities": 63400000,
    "notionalamount": 25900000,
    "proceedsfromissueofordinaryshares": 131900000,
    "proceedsfromissueofbondsnotesanddebentures": 73400000,
    "shareprice": 9.86,
    "nameofsubsidiary": "Fasteignafelagið Sæmundur hf",
    "nameofjointventure": "Alvotech & CCHN Biopharmaceutical Co. Ltd",
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Biopharm",
    "numberofsharesissuedandfullypaid": 110000021,
    "countryofincorporationorresidenceofsubsidiary": "Iceland",
    "countryofincorporationofjointventure": "China",
    "proportionofownershipinterestinjointventure": 0.5,
    "depreciationmethodpropertyplantandequipment": "Depreciation is calculated and recognized as an expense on a straight-line basis over an asset’s estimated useful life.",
    "upfrontpayment": 7500000,
    "amountspayablerelatedpartytransactions": 163289000,
    "othernoncurrentliabilities": 13500000,
    "inventorywritedown2011": 2100000,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": 7,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": 5,
    "revenuefromcontractswithcustomers": 57769000,
    "noncurrentassetsotherthanfinancialinstrumentsdeferredtaxassetspostemploymentbenefitassetsandrightsarisingunderinsurancecontracts": 338792000,
    "revenue": 38376000,
    "percentageofentitysrevenue": 0.462,
    "contractassets": 28656000,
    "increasedecreasethroughcumulativecatchupadjustmentstorevenuecontractassets": 29823000,
    "contractassetsadditionsamountstransferredtotradereceivables": -19690000,
    "contractliabilities": 93932000,
    "contractliabilitycustomerprepayments": 46127000,
    "increasedecreasethroughcumulativecatchupadjustmentstorevenuearisingfromchangeinmeasureofprogresscontractliabilities": -26782000,
    "contractassetsliabilitiesforeigncurrencyadjustment": 51000,
    "noncurrentcontractassetsmaterializeperiod": 3,
    "noncurrentcontractliabilitiesrevenuerecognitionperiod": 5,
    "wagesandsalaries": 92082000,
    "postemploymentbenefitexpensedefinedcontributionplans": 10052000,
    "otherlongtermbenefits": 5481000,
    "expensefromsharebasedpaymenttransactionswithemployees": 10317000,
    "otheremployeeexpense": 11670000,
    "temporarylabourexpense": 5838000,
    "employeebenefitsexpense": 4300000,
    "averagenumberofemployees": 858000,
    "gainsonchangeinfairvalueofderivatives": 1637000,
    "interestincomeoncashandcashequivalents": 556000,
    "interestincomeonotherfinancialassets": 356000,
    "lossesonchangeinfairvalueofderivatives": 96981000,
    "interestexpenseonborrowings": 71452000,
    "consentingfee": 7430000,
    "lossonremeasurementofbonds": 6511000,
    "interestexpenseonleaseliabilities": 6022000,
    "amortizationofdeferreddebtissuancecosts": 23000,
    "depreciationandimpairmentofpropertyplantandequipment": 9807000,
    "depreciationrightofuseassets": -327000,
    "amortizationandimpairmentofintangibleassets": 3488000,
    "depreciationamortisationandimpairmentlossreversalofimpairmentlossrecognisedinprofitorloss": 3354000,
    "auditorsremunerationforauditservices": 2615000,
    "auditorsremunerationfortaxservices": 676000,
    "auditorsremuneration": 3291000,
    "currenttaxexpenseincome": 1015000,
    "adjustmentsforcurrenttaxofpriorperiod": -115000,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": 900000,
    "deferredtaxexpenseincome": -54236000,
    "adjustmentsfordeferredtaxofpriorperiods": 15269000,
    "deferredtaxexpenseincomeandadjustmentsfordeferredtaxofpriorperiods": -38967000,
    "applicabletaxrate": 0.249,
    "taxrateeffectofforeigntaxrates": -0.024,
    "taxrateeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": -0.08900000000000001,
    "taxrateeffectofnonrecognitionoftaxlosses": -0.038,
    "othertaxrateeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": -0.028999999999999998,
    "averageeffectivetaxrate": 0.069,
    "deferredtaxliabilityasset": 209187000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": 38919000,
    "netdeferredtaxassets": 6832000,
    "netdeferredtaxliabilities": 2900000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 1082511000,
    "weightedaverageshares": 197721710,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershare": 148857998,
    "increasedecreasethroughtransferspropertyplantandequipment": -5985000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 153219000,
    "disposalspropertyplantandequipment": -2597000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -23000,
    "depreciationpropertyplantandequipment": 9807000,
    "impairmentlossrecognisedinprofitorloss": 700000,
    "propertyplantandequipmentpledgedassecurity": 122400000,
    "adjustmentsforindexedleasesrightofuseassets": 10201000,
    "additionstorightofuseassets": 9583000,
    "derecognitionduetoassetacquisition": -88941000,
    "translationdifferencerightofuseassets": -274000,
    "leaseliabilities": 40532000,
    "leaseliabilitiesadjustmentsforindexedleases": 10247000,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 7458000,
    "cashoutflowforleases": -7655000,
    "derecognitionduetoassetsacquisition": -80075000,
    "leaseliabilitiesforeigncurrencyadjustment": -11682000,
    "leaseliabilitiestranslationdifference": 99000,
    "foreigncurrencydifferenceonleaseliability": 11682000,
    "lossfromextinguishmentofleaseliabilities": -3859000,
    "leasecostrecognizedinprofitandloss": -8068000,
    "grossleaseliabilities": 48434000,
    "expenserelatingtoshorttermleasesandleasesoflowvalueassetsforwhichrecognitionexemptionhasbeenused": 100000,
    "increasedecreasethroughnetexchangedifferencesgoodwill": -724000,
    "descriptionofgrowthrateusedtoextrapolatecashflowprojections": 0.05,
    "descriptionofdiscountratesappliedtocashflowprojections": 0.276,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 7682000,
    "impairmentlossrecognisedinprofitorlossintangibleassetsotherthangoodwill": -2755000,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsotherthangoodwill": -117000,
    "amortisationintangibleassetsotherthangoodwill": 733000,
    "impairmentloss": 2800000,
    "additionrestrictedcashandcashequivalents": 14914000,
    "interestincomeoncash": 186000,
    "rawmaterialsandconsumablesused": 41961000,
    "workinprogress": 29450000,
    "finishedgoods": 2121000,
    "inventoryreserves": -2062000,
    "inventoriestotal": 8500000,
    "currentvalueaddedtaxreceivables": 6468000,
    "currentprepaidexpenses": 20601000,
    "proceedsreceivablefromconvertiblebonds": 3520000,
    "derivaiveassets": 851000,
    "othercurrentreceivables": 1509000,
    "numberofsharesissued": 252160087,
    "sharecapitalandsharepremium": 1060558000,
    "numberofsharesoutstanding": 1133131,
    "increasethroughpipefinancingshares": 17493000,
    "eliminationofpredecessorordinaryshares": -13481799,
    "issuanceofordinaryshares": 186576505,
    "issueofpredecessorearnoutshares": 38330000,
    "issueofoacbearnoutshares": 1250000,
    "issueofsharesonsettlementofshareappreciationrightsshares": 3510582,
    "issueofsharesonsettlementofrelatedpartyloansshares": 5000000,
    "shareissuerelatedcost": -5562000,
    "increasethroughpipefinancingvalue": 174930000,
    "eliminationofpredecessorordinaryvalue": 135000,
    "issuanceofordinaryvalue": 65035000,
    "issueofpredecessorearnoutsharesvalue": -227500000,
    "issueofoacbearnoutsharesvalue": -9100000,
    "issueofsharesonsettlementofshareappreciationrightsvalue": 30302000,
    "issueofsharesonsettlementofrelatedpartyloansvalue": 32200000,
    "commonstockheldbysubsidiary": 27072167,
    "bondsissued": 530506000,
    "loansreceived": 64588000,
    "otherborrowings": 71242000,
    "borrowings": 40830000,
    "paymentsfordebtissuecost": 2889000,
    "accretionderecognitionofborrowingsdiscount": 35065000,
    "recognitionofnewborrowingsdiscount": -43241000,
    "proceedsfromborrowingclassifiedasfinancingactivities": 467196000,
    "loansfromrelatedpartyconvertedtoequity": -50000000,
    "repaymentsofborrowingclassifiedasfinancingactivities": 83951000,
    "debtinstrumentincreaseaccruedinterest": 40424000,
    "amortizationofdeferreddebtissuecosts": 23000,
    "increasedecreasethrougheffectofchangesinforeignexchangeratesliabilitiesarisingfromfinancingactivities": 1032000,
    "borrowingsinterestrate": 0.1241,
    "borrowingsadjustmenttointerestratebasis": 0.0495,
    "gainslossesrecognisedinprofitorlossexcludingexchangedifferencesfairvaluemeasurementliabilities": 6500000,
    "feeandcommissionexpense": 7400000,
    "minimumamountofrestrictedcashtobemaintained": 25000000,
    "classofwarrantsorrightsexercisepricepershare": 11.5,
    "gainlossonextinguishmentofdebtincludingchangeinfairvalue": 40900000,
    "transactioncosts": 12100000,
    "recognitionofderivativeasset": 4600000,
    "recognitionofderivativeliabilitiesatfairvalue": 15400000,
    "interestpayable": 300000,
    "carryingvalueofdebtextinguished": 440100000,
    "accruedinterestondebtextinguished": 4800000,
    "liabilityassetofdefinedbenefitplans": 544000,
    "contributionstoplannetdefinedbenefitliabilityasset": 5075000,
    "paymentsfromplannetdefinedbenefitliabilityasset": -7693000,
    "liabilityassetofdefinedbenefitplanspriortoreclassification": 12317000,
    "reclassifiedtoothercurrentliabilitiesnetdefinedbenefitliabilityasset": -11773000,
    "numberofemployees": 1,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 150000,
    "numberofyearforissuingsharesaftertheclosingofthebusinesscombination": "one year",
    "increasedecreaseinnetdefinedbenefitliabilityasset": 36800000,
    "changesinequity": 31000000,
    "increasedecreasethroughothercurrentliabilitiesandincomenetdefinedbenefitliabilityasset": 1500000,
    "settlementofcashoptionasaliabilityfairvalue": 800000,
    "settlementofshareoptionasaequityfairvalue": 700000,
    "othercurrentfinancialliabilities": 700000,
    "numberofinstrumentsotherequityinstrumentsgranted": 7659049,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": -679563,
    "weightedaveragefairvaluepershareotherequityinstrumentsgranted": 6.68,
    "weightedaveragefairvaluepershareotherequityinstrumentsvested": 6.3,
    "weightedaveragefairvaluepershareotherequityinstrumentsoutstanding": 6.72,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 10317000,
    "descriptionofvestingrequirementsforsharebasedpaymentarrangement": "Compensation expense for RSUs is determined based upon the market price of the Ordinary Shares underlying the awards on the date of grant and expensed over the vesting period, which is generally a one to four-year period, with a 1-year cliff vesting period and subsequent monthly vesting, resulting from participates completing a service condition.",
    "expensefromequitysettledsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 10300000,
    "legalfees": 8700000,
    "servicesreceivedrelatedpartytransactions": 21141000,
    "revenuefromrenderingofservicesrelatedpartytransactions": 818000,
    "amountsreceivablerelatedpartytransactions": 1548000,
    "directorsfees": 927000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 6292000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 608000,
    "keymanagementpersonnelcompensationterminationbenefits": 1977000,
    "keymanagementpersonnelcompensationotherlongtermbenefits": 5015000,
    "lesseeoperatingleaseremainingleaseterm": 8,
    "currentaccruedsalaryandsalaryrelatedexpenses": 15620000,
    "currentaccruedinterest": 2249000,
    "currentaccruedvacation": 5025000,
    "currentemployeeincentiveplan": 12433000,
    "currentaccruedexpensesandothercurrentliabilities": 18720000,
    "principalplaceofbusinessofjointventure": "China",
    "shareofgainslossesofjointventuresonexchangedifferencesontranslationnetoftax": -4149000,
    "cashandbankbalancesatcentralbanks": 17203000,
    "currentfinancialliabilities": 145000,
    "netassetsliabilities": -506000,
    "otherincomeexpensenet": -8297000,
    "revenuefrominterest": 433000,
    "depreciationandamortisationexpense": 829000,
    "interestexpense": 151000,
    "otherexpensebynature": 4633000,
    "othercomprehensiveloss": -5180000,
    "othercurrentasset": 5880000,
    "othernoncurrentasset": 4484000,
    "financialassetsatamortisedcost": 136498000,
    "othercurrentliability": 53664000,
    "financialliabilitiesatamortizedcostandfinancialliabilitiesatfairvaluethroughprofitorloss": 1297301000,
    "bondsissuedatfairvalue": 535167000,
    "derivativefinancialliabilities": 381083000,
    "significantunobservableinputliabilities": 4.1,
    "increasedecreaseinfairvaluemeasurementduetoreasonablypossibleincreaseinunobservableinputrecognisedinprofitorlossbeforetaxliabilities": -51000,
    "increasedecreaseinfairvaluemeasurementduetoreasonablypossibledecreaseinunobservableinputrecognisedinprofitorlossbeforetaxliabilities": 51000,
    "percentageofreasonablypossibleincreaseinunobservableinputliabilities": 0.1,
    "percentageofreasonablypossibledecreaseinunobservableinputliabilities": 0.1,
    "closingforeignexchangerate": 0.012,
    "averageforeignexchangerate": 0.013,
    "percentagechangeinforeignexchangerate": 0.10099999999999999,
    "maximumexposuretocreditrisk": 136498000,
    "financialassetsundiscountednoninterestbearingloansreceivable": 40400000,
    "financialassetsundiscountedvariableinterestbearingloansreceivable": 96098000,
    "financialassetsheldformanagingliquidityrisk": 136498000,
    "noninterestbearingundiscountedcashflowsliabilities": 112350000,
    "bondsissuedundiscountedcashflows": 1008986000,
    "derivativefinancialliabilitiesundiscountedcashflows": 380232000,
    "bankborrowingsundiscountedcashflows": 92404000,
    "financialliabilitiesderivativesandnonderivativesundiscontinuedcashflows": 1593972000,
    "gainslossesrecognisedinprofitorlossfairvaluemeasurementliabilities": 1600000,
    "warrantsasapercentageoffullydilutedsharecapital": 0.01,
    "minimumproceedsfromtheissuanceofcommonstock": 150000000,
    "classofwarrantsorrightsissuedduringtheperiodexercisepricepershare": 0.01,
    "increasedecreaseinnumberofordinarysharesissued": 1250000,
    "vestingpercentageofshares": 0.5,
    "aggregateperiodfordeterminingtheshareprice": "five years",
    "thresholddaysfordeterminingtheshareprice": "P10D",
    "numberofconsecutivetradingdays": "P20D",
    "classofwarrantsorrightsoutstanding": 10916647,
    "capitalexpendituretangibleassetsincurredbutnotpaid": 4131000,
    "capitalexpenditureintangibleassetsincurredbutnotpaid": 4075000,
    "rightofuseassetsobainedthroughnewoperatingleaseliabilites": 9583000,
    "additionoftheloanfacilitiesthroughconvertiblebond": 115005000,
    "noncashissuanceofconvertiblebond": 80000000,
    "ordinarysharesvalueissuedconversionofborrowings": 32200000
  }
]